Gender differences in health-related quality of life among cannabis users: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 22143039)

Published in Drug Alcohol Depend on December 03, 2011

Authors

Shaul Lev-Ran1, Sameer Imtiaz, Benjamin J Taylor, Kevin D Shield, Jürgen Rehm, Bernard Le Foll

Author Affiliations

1: Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada. shauli.levran@gmail.com

Articles citing this

Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. JAMA Psychiatry (2015) 2.44

Investigation of sex-dependent effects of cannabis in daily cannabis smokers. Drug Alcohol Depend (2014) 1.08

Prevalence and Correlates of DSM-5 Cannabis Use Disorder, 2012-2013: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Am J Psychiatry (2016) 1.02

Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study. J Psychiatr Res (2013) 0.98

Cannabis or alcohol first? Differences by ethnicity and in risk for rapid progression to cannabis-related problems in women. Psychol Med (2012) 0.93

Cannabis Abusers Show Hypofrontality and Blunted Brain Responses to a Stimulant Challenge in Females but not in Males. Neuropsychopharmacology (2016) 0.87

Sex, age, and progression of drug use in adolescents admitted for substance use disorder treatment in the northeastern United States: comparison with a national survey. Subst Abus (2013) 0.85

Body mass index and health-related quality of life among young Swiss men. BMC Public Health (2013) 0.83

Health-related quality of life in patients with dual diagnosis: clinical correlates. Health Qual Life Outcomes (2012) 0.82

Effect of a primary care based brief intervention trial among risky drug users on health-related quality of life. Drug Alcohol Depend (2014) 0.79

US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013. JAMA Psychiatry (2017) 0.77

Cannabis use is a better indicator of poor mental health in women than in men: a cross-sectional study in young adults from the general population. Community Ment Health J (2014) 0.76

Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences. Biol Sex Differ (2017) 0.75

Association between cannabis use and treatment outcomes in patients receiving methadone maintenance treatment: a systematic review protocol. Syst Rev (2016) 0.75

RELATIONSHIP OF ASSESS SELF-ESTEEM AND LOCUS OF CONTROL WITH QUALITY OF LIFE DURING TREATMENT STAGES IN PATIENTS REFERRING TO DRUG ADDICTION REHABILITATION CENTERS. Mater Sociomed (2016) 0.75

Gender Differences in Internalizing Symptoms and Suicide Risk Among Men and Women Seeking Treatment for Cannabis Use Disorder from Late Adolescence to Middle Adulthood. J Subst Abuse Treat (2016) 0.75

Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study. Am J Addict (2017) 0.75

Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life. J Subst Abuse Treat (2017) 0.75

Articles by these authors

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet (2013) 16.76

The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med (2009) 12.13

Alcohol and public health. Lancet (2005) 10.82

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Risky single-occasion drinking: bingeing is not bingeing. Addiction (2010) 4.63

The cardioprotective association of average alcohol consumption and ischaemic heart disease: a systematic review and meta-analysis. Addiction (2012) 3.74

Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. JAMA Psychiatry (2013) 3.71

Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ (2010) 3.31

The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study. Int J Epidemiol (2013) 3.23

Alcohol as a risk factor for type 2 diabetes: A systematic review and meta-analysis. Diabetes Care (2009) 3.03

Irregular heavy drinking occasions and risk of ischemic heart disease: a systematic review and meta-analysis. Am J Epidemiol (2010) 2.49

Are the 1976-1985 birth cohorts heavier drinkers? Age-period-cohort analyses of the National Alcohol Surveys 1979-2010. Addiction (2012) 2.42

Alcohol consumption and the risk of morbidity and mortality for different stroke types--a systematic review and meta-analysis. BMC Public Health (2010) 2.42

Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis. J Stud Alcohol (2004) 2.38

Alcohol as a correlate of unprotected sexual behavior among people living with HIV/AIDS: review and meta-analysis. AIDS Behav (2009) 2.33

Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health (2009) 2.23

Causal considerations on alcohol and HIV/AIDS--a systematic review. Alcohol Alcohol (2010) 2.22

Changes in illicit opioid use across Canada. CMAJ (2006) 2.20

Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). Can J Psychiatry (2006) 2.16

Carcinogenicity of acetaldehyde in alcoholic beverages: risk assessment outside ethanol metabolism. Addiction (2009) 2.06

Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studies. Addiction (2012) 2.04

Age, period and cohort influences on beer, wine and spirits consumption trends in the US National Alcohol Surveys. Addiction (2004) 2.01

The burden of cancer attributable to alcohol drinking. Int J Cancer (2006) 2.01

Age-period-cohort modelling of alcohol volume and heavy drinking days in the US National Alcohol Surveys: divergence in younger and older adult trends. Addiction (2009) 1.98

Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ (2011) 1.94

Alcohol consumption and non-communicable diseases: epidemiology and policy implications. Addiction (2011) 1.93

Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States. J Affect Disord (2011) 1.91

Multicentre study of acute alcohol use and non-fatal injuries: data from the WHO collaborative study on alcohol and injuries. Bull World Health Organ (2006) 1.90

Heroin-assisted treatment as a response to the public health problem of opiate dependence. Eur J Public Health (2002) 1.89

Comparing alcohol consumption in central and eastern Europe to other European countries. Alcohol Alcohol (2007) 1.89

How stable is the risk curve between alcohol and all-cause mortality and what factors influence the shape? A precision-weighted hierarchical meta-analysis. Eur J Epidemiol (2003) 1.85

Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations. Can J Public Health (2011) 1.81

Effects of depression and social integration on the relationship between alcohol consumption and all-cause mortality. Addiction (2002) 1.78

Harmful alcohol use. Alcohol Res Health (2003) 1.74

Alcohol consumption, unprovoked seizures, and epilepsy: a systematic review and meta-analysis. Epilepsia (2010) 1.73

Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Health (2005) 1.73

Use of other opioids during methadone therapy: a population-based study. Addiction (2012) 1.72

Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend (2007) 1.71

Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010. Pharmacoepidemiol Drug Saf (2011) 1.69

Global burden of alcoholic liver diseases. J Hepatol (2013) 1.67

Antidepressant exposure during pregnancy and congenital malformations: is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry (2013) 1.65

The burden of death, disease, and disability due to alcohol in New Zealand. N Z Med J (2005) 1.61

What can the Swiss and Dutch trials tell us about the potential risks associated with heroin prescribing? Drug Alcohol Rev (2003) 1.57

Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. JOP (2009) 1.57

Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia. Eur J Gastroenterol Hepatol (2008) 1.56

Multi-level analysis of alcohol-related injury among emergency department patients: a cross-national study. Addiction (2005) 1.53

Age-period-cohort influences on trends in past year marijuana use in the US from the 1984, 1990, 1995 and 2000 National Alcohol Surveys. Drug Alcohol Depend (2006) 1.52

Using latent class analysis (LCA) to analyze patterns of drug use in a population of illegal opioid users. Drug Alcohol Depend (2006) 1.51

International regulation of alcohol. BMJ (2008) 1.48

Alcohol use disorders and mortality: a systematic review and meta-analysis. Addiction (2013) 1.48

Alcohol-attributable cancer deaths and years of potential life lost in the United States. Am J Public Health (2013) 1.46

Crack across Canada: Comparing crack users and crack non-users in a Canadian multi-city cohort of illicit opioid users. Addiction (2006) 1.45

Determinants of overdose incidents among illicit opioid users in 5 Canadian cities. CMAJ (2004) 1.44

Average volume of alcohol consumption and all-cause mortality in African Americans: the NHEFS cohort. Alcohol Clin Exp Res (2003) 1.42

Understanding the parameters of non-medical use of prescription drugs: moving beyond mere numbers. Addiction (2007) 1.42

Non-medical use of prescription opioids and public health in Canada: an urgent call for research and interventions development. Can J Public Health (2008) 1.41

The effectiveness of psychosocial modalities in the treatment of alcohol problems in adults: a review of the evidence. Can J Psychiatry (2012) 1.40

Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics. J Urban Health (2007) 1.40

Does the association between alcohol consumption and depression depend on how they are measured? Alcohol Clin Exp Res (2007) 1.38

Alcohol consumption as a risk factor for atrial fibrillation: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil (2010) 1.38

Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction. Biol Psychiatry (2010) 1.38

Difficulties with telephone-based surveys on alcohol consumption in high-income countries: the Canadian example. Int J Methods Psychiatr Res (2012) 1.34

Global alcohol exposure estimates by country, territory and region for 2005--a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. Addiction (2013) 1.32

Surrogate alcohol: what do we know and where do we go? Alcohol Clin Exp Res (2007) 1.30

Does price matter? The effect of decreased price on spirits consumption in Switzerland. Alcohol Clin Exp Res (2003) 1.30

Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J Biol Chem (2008) 1.30

Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample. Am J Addict (2013) 1.29

Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats. J Pharmacol Exp Ther (2008) 1.29

The impact of tobacco tax cuts on smoking initiation among Canadian young adults. Am J Prev Med (2006) 1.28

Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009. Drug Alcohol Depend (2010) 1.26

Clear criteria based on absolute risk: reforming the basis of guidelines on low-risk drinking. Drug Alcohol Rev (2011) 1.26

A systematic review of the epidemiology of unrecorded alcohol consumption and the chemical composition of unrecorded alcohol. Addiction (2014) 1.25

Chronic diseases and conditions related to alcohol use. Alcohol Res (2013) 1.24

Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe. Eur Addict Res (2010) 1.22

Alcohol consumption and mortality in Russia since 2000: are there any changes following the alcohol policy changes starting in 2006? Alcohol Alcohol (2013) 1.22

How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey. Tob Control (2011) 1.22

Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use. Drug Alcohol Rev (2006) 1.21

Alcohol and infectious diseases: an overlooked causal linkage? Addiction (2009) 1.21

Obesity and cannabis use: results from 2 representative national surveys. Am J Epidemiol (2011) 1.20

What is best evidence in epidemiology? A reply to Stockwell (2012): the journal publishes both invited and unsolicited letters. Addiction (2013) 1.20

Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration--comparison with CB(1) receptor blockade. Psychopharmacology (Berl) (2009) 1.19

Recall bias in case-crossover designs studying the potential influence of alcohol consumption. J Stud Alcohol Drugs (2010) 1.19

Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors. Biol Psychiatry (2011) 1.18

Ischemic heart disease mortality and morbidity rates in former drinkers: a meta-analysis. Am J Epidemiol (2010) 1.18

Prescription drug abuse in Canada and the diversion of prescription drugs into the illicit drug market. Can J Public Health (2005) 1.18

Changes in alcohol consumption following a reduction in the price of spirits: a natural experiment in Switzerland. Addiction (2003) 1.16

The relationship between self-reported drinking and BAC level in emergency room injury cases: is it a straight line? Alcohol Clin Exp Res (2010) 1.16

The composition of alcohol products from markets in Lithuania and Hungary, and potential health consequences: a pilot study. Alcohol Alcohol (2008) 1.16

Externalities from alcohol consumption in the 2005 US National Alcohol Survey: implications for policy. Int J Environ Res Public Health (2009) 1.16

Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction. Neuropsychopharmacology (2010) 1.15

Mortality and potential years of life lost attributable to alcohol consumption in Canada in 2005. BMC Public Health (2012) 1.15

Social cost of heavy drinking and alcohol dependence in high-income countries. Int J Public Health (2009) 1.14

Pharmacotherapy of alcohol use disorders and concurrent psychiatric disorders: a review. Can J Psychiatry (2012) 1.12

Global alcohol-attributable deaths from cancer, liver cirrhosis, and injury in 2010. Alcohol Res (2013) 1.12